Literature DB >> 4557030

Clinical evaluation of co-trimoxazole and furazolidone in treatment of shigellosis in children.

U Lexomboon, P Mansuwan, C Duangmani, P Benjadol, M T M'cMinn.   

Abstract

Co-trimoxazole (trimethoprim-sulphamethoxazole) was compared with furazolidone in the treatment of shigellosis in two groups of 33 and 30 patients respectively. Those treated with co-trimoxazole recovered more quickly; none had shigellae in the faeces four days after the start of treatment, whereas in the group given furazolidone eight still had positive stool cultures seven days after treatment.The susceptibility of 104 shigella strains to seven antimicrobial agents was studied by plate dilution technique. All agents but tetracycline and chloramphenicol were found highly effective against most of the strains tested. All shigella isolates were resistant to sulphamethoxazole, and 63% were sensitive to trimethoprim. Potentiation of trimethoprim by sulphamethoxazole was shown in that all strains tested became sensitive to the combination of trimethoprim and sulphamethoxazole in a ratio of 1:20.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4557030      PMCID: PMC1788506          DOI: 10.1136/bmj.3.5817.23

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  10 in total

1.  DIARRHEAL DISEASES OF CHILDREN. THE OCCURRENCE OF ENTEROPATHOGENIC VIRUSES AND BACTERIA.

Authors:  M RAMOS-ALVAREZ; J OLARTE
Journal:  Am J Dis Child       Date:  1964-03

2.  Shigellosis and sulphonamides.

Authors:  D C TURK
Journal:  Lancet       Date:  1960-08-27       Impact factor: 79.321

3.  Observations on resistance to sulfadiazine and antibiotics in shigellosis.

Authors:  K MARBERG; G ALTMANN; A ESHKOLBRUCK
Journal:  Am J Trop Med Hyg       Date:  1958-01       Impact factor: 2.345

4.  Observations on the association of enteric viruses and bacteria with diarrhea.

Authors:  M H Goodwin; G J Love; D C Mackel; K R Berquist; R S Ganelin
Journal:  Am J Trop Med Hyg       Date:  1967-03       Impact factor: 2.345

5.  [Experience with the combination sulfamethoxazole and trimethoprim in the treatment of Shigella-Flexner infections].

Authors:  T Freiberg
Journal:  Arzneimittelforschung       Date:  1971-05

6.  Determination of biotype, phage type and colicinogenic character of Shigella sonnei, and its epidemiologic importance.

Authors:  S Szturm-Rubinsten
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  1968       Impact factor: 4.291

7.  [Resistance determinations in microorganisms causing dysenteria with regard to sulfamethoxazol-trimethoprim].

Authors:  W Titze
Journal:  Arzneimittelforschung       Date:  1971-05

8.  Double-blind treatment study of shigellosis comparing ampicillin, sulfadiazine, and placebo.

Authors:  K C Haltalin; J D Nelson; R Ring; M Sladoje; L V Hinton
Journal:  J Pediatr       Date:  1967-06       Impact factor: 4.406

9.  EPITHELIAL CELL PENETRATION AS AN ESSENTIAL STEP IN THE PATHOGENESIS OF BACILLARY DYSENTERY.

Authors:  E H Labrec; H Schneider; T J Magnani; S B Formal
Journal:  J Bacteriol       Date:  1964-11       Impact factor: 3.490

10.  Colicin typing as an epidemiological tool in the investigation of outbreaks of Shigella sonnei.

Authors:  L B Reller
Journal:  Appl Microbiol       Date:  1971-01
  10 in total
  7 in total

1.  In vitro susceptibility of Shigella strains to trimethoprim and sulfamethoxazole.

Authors:  R C Rudoy; J D Nelson; K C Haltalin
Journal:  Antimicrob Agents Chemother       Date:  1974-05       Impact factor: 5.191

Review 2.  Antibiotic therapy for Shigella dysentery.

Authors:  Prince Rh Christopher; Kirubah V David; Sushil M John; Venkatesan Sankarapandian
Journal:  Cochrane Database Syst Rev       Date:  2010-08-04

Review 3.  Pharmacoeconomics of the therapy of diarrhoeal disease.

Authors:  K A Nathavitharana; I W Booth
Journal:  Pharmacoeconomics       Date:  1992-10       Impact factor: 4.981

4.  Antimicrobial susceptibilities of shigellae isolated in Houston, Texas, in 1974.

Authors:  P A Byers; H L Dupont; M C Goldschmidt
Journal:  Antimicrob Agents Chemother       Date:  1976-02       Impact factor: 5.191

5.  Furazolidone versus ampicillin in the treatment of traveler's diarrhea.

Authors:  H L DuPont; C D Ericsson; E Galindo; L V Wood; D Morgan; J A Bitsura; J G Mendiola
Journal:  Antimicrob Agents Chemother       Date:  1984-08       Impact factor: 5.191

6.  Rifampicin therapy in shigellosis in infancy.

Authors:  Y Naveh; P Strahovsky; A Friedman
Journal:  Arch Dis Child       Date:  1977-12       Impact factor: 3.791

7.  Shigella species from Addis Ababa: frequency of isolation and in vitro drug sensitivity.

Authors:  M Gedebou; A Tassew
Journal:  J Hyg (Lond)       Date:  1982-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.